POSTER: MM-613 Healthcare Resource Utilization and Costs Among Patients With Relapsed/Refractory Multiple Myeloma Treated With Chimeric Antigen Receptor-T (CAR-T) Cell Therapy
Saved in:
Published in: | Clinical lymphoma, myeloma and leukemia Vol. 23; p. S223 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Elsevier Inc
01-09-2023
|
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Author | Adams, Shayna Kohli, Monal Fu, Alex Huo, Stephen Foster, Miran Kharat, Akshay Jagannath, Sundar Umeh, Emeka |
---|---|
Author_xml | – sequence: 1 givenname: Sundar surname: Jagannath fullname: Jagannath, Sundar organization: Icahn School of Medicine at Mount Sinai, New York, USA – sequence: 2 givenname: Akshay surname: Kharat fullname: Kharat, Akshay organization: Janssen Scientific Affairs, Horsham, USA – sequence: 3 givenname: Alex surname: Fu fullname: Fu, Alex organization: Janssen Scientific Affairs, Horsham, USA – sequence: 4 givenname: Stephen surname: Huo fullname: Huo, Stephen organization: Janssen Scientific Affairs, Horsham, USA – sequence: 5 givenname: Monal surname: Kohli fullname: Kohli, Monal organization: STATInMED LLC, Dallas, USA – sequence: 6 givenname: Shayna surname: Adams fullname: Adams, Shayna organization: STATInMED LLC, Dallas, USA – sequence: 7 givenname: Emeka surname: Umeh fullname: Umeh, Emeka organization: STATInMED LLC, Dallas, USA – sequence: 8 givenname: Miran surname: Foster fullname: Foster, Miran organization: STATInMED LLC, Dallas, USA |
BookMark | eNqFkE1rGzEQhkVJoPn6CQUdk8M2-tjVWr0Us6RNICbB2ZCjmEjjWEVeLZJScP9U_2LWcei1p5l54XkZnmNyMMQBCfnC2VfOuLp8ELwRlVANOxfygrFZ3Vb6Ezn6iJU--Lc37DM5zvkXYy1jXB-Rv_d3D_3V8htdLCrFJb1GCGVtISFdYo6vySJ9LD74P1B8HCgMjnYxl0znmzi80PspxmE6n3xZT0iAMaO7XOIqgS0xbeniNRQ_BqSLLYa4AdonhIJuT3Rrv8HkLZ0Pxb_gMFVYHCew6ul5N19W_QXtMATarzHBuD0lhysIGc8-5gl5_HHVd9fV7d3Pm25-W1lea11JNYMa7KpBxV0raxCNRKncrHVK6JpBq63QyBuLoKGttWLaPkvRPrcORK3lCWn2vTbFnBOuzJj8BtLWcGZ21s27dbNTaoQ079bNjvu-53B67rfHZLKdBFl0PqEtxkX_n4Y3GieLsA |
ContentType | Journal Article |
Copyright | 2023 Elsevier Inc. |
Copyright_xml | – notice: 2023 Elsevier Inc. |
DBID | AAYXX CITATION |
DOI | 10.1016/S2152-2650(23)00847-9 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2152-2669 |
EndPage | S223 |
ExternalDocumentID | 10_1016_S2152_2650_23_00847_9 S2152265023008479 |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 1P~ 1~. 4.4 457 4G. 53G 5VS 6PF 7-5 8P~ AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAWTL AAXUO ABBQC ABLVK ABMAC ABMZM ABXDB ABYKQ ACDAQ ACGFS ACRLP ADBBV ADEZE ADMUD AEBSH AEKER AENEX AEVXI AFCTW AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV C45 CAG COF DU5 EBS EFJIC EFLBG EJD EMB EMOBN F5P FDB FEDTE FIRID FNPLU FYGXN GBLVA HVGLF HZ~ KOM LCYCR M41 MET MO0 O-L O9- OAUVE OC~ OO- OVD P-8 P-9 PC. Q38 ROL SDF SEL SES SPCBC SSH SSZ SV3 T5K TEORI XH2 Z5R ~G- AAXKI AAYXX AFJKZ AKRWK CITATION |
ID | FETCH-LOGICAL-c1499-368a4acf5e61d734a253e36d87d62940a79c29e15cea9a749609cb327b7da2493 |
ISSN | 2152-2650 |
IngestDate | Thu Sep 26 16:48:30 EDT 2024 Fri Feb 23 02:35:53 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c1499-368a4acf5e61d734a253e36d87d62940a79c29e15cea9a749609cb327b7da2493 |
OpenAccessLink | https://doi.org/10.1016/s2152-2650(23)00847-9 |
ParticipantIDs | crossref_primary_10_1016_S2152_2650_23_00847_9 elsevier_sciencedirect_doi_10_1016_S2152_2650_23_00847_9 |
PublicationCentury | 2000 |
PublicationDate | September 2023 2023-09-00 |
PublicationDateYYYYMMDD | 2023-09-01 |
PublicationDate_xml | – month: 09 year: 2023 text: September 2023 |
PublicationDecade | 2020 |
PublicationTitle | Clinical lymphoma, myeloma and leukemia |
PublicationYear | 2023 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
SSID | ssj0070019 |
Score | 2.3705773 |
SourceID | crossref elsevier |
SourceType | Aggregation Database Publisher |
StartPage | S223 |
Title | POSTER: MM-613 Healthcare Resource Utilization and Costs Among Patients With Relapsed/Refractory Multiple Myeloma Treated With Chimeric Antigen Receptor-T (CAR-T) Cell Therapy |
URI | https://dx.doi.org/10.1016/S2152-2650(23)00847-9 |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtZ1La9tAEIAXJ4HSS-mTpi_20EOCURLvyl5tb8a1SQNuQ-xAbmKlXcUmfhHbB_-q_sXO7ENSaCltoRdhr7Vao_nQzozmQchHabQyjGkwU7WOYthDIpUlMbBs4rbhQiU2F-Z8JL7eJJ_7cb_RCL1Dq7H_KmkYA1lj5uxfSLu8KAzAZ5A5HEHqcPwjuV9-G4GGiob-cAgWG_eJRjbCK_jqm9eb6cwnYNq3B73lerNudm3joUtXaRUDYzcTGyy3WqNHdHBlinvbnWfXHIYwxOHOzJZz1Ryj7gm6q53Tm0xdhH53scFin6ibmhVMjMb2pXH3KhqjN6JnbOPQqqxBqJgQsjVnO2ANLo8czP1K-HdnZntn5tNyR7lQt2qBbwFcnBH6RsqNBAtSu9IKd-tJFTE02Ib0ngrsZS3sre4NYbwM9_IuupCm8yCKFHv3RqzjKtyemPqY6xMTtgLGa8_yEfNfzYOvP-05zv0xKheBG4nVMCS2KhCRrDbaMvzRnoungv2HJ8k9csDgQQnP6YPul_7NRdAlMCgADbjy2lUO2mm14BHjx36xX2tXNY1p_JQ88aYO7TpGn5GGWTwnj4Y-mOMF-e5Q_UQdqLQClQZQaQ1UCpKnFlRqQaUBVIrQ0QDqaYUpDZhSjyn1mLoZAVPqMaUVpvTIQnpMEVHqEX1Jrgf9ce888v1DohzsfhnxTqJilRdt02lpwWPF2tzwjk6E7jAZnykhcyZNq50bJZWIsfhinnEmMqEViyV_RfYXy4V5TajR-VkCv-cyAxVc5irTRSFExtsqkYkpDslJuO_pypWJScv4SRRUioJKGU-toFJ5SJIgndTruk6HTQGr30998-9T35LHWKoFda-WfEf2N_db857srfX2gyfvB1Pjx0g |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=POSTER%3A+MM-613+Healthcare+Resource+Utilization+and+Costs+Among+Patients+With+Relapsed%2FRefractory+Multiple+Myeloma+Treated+With+Chimeric+Antigen+Receptor-T+%28CAR-T%29+Cell+Therapy&rft.jtitle=Clinical+lymphoma%2C+myeloma+and+leukemia&rft.au=Jagannath%2C+Sundar&rft.au=Kharat%2C+Akshay&rft.au=Fu%2C+Alex&rft.au=Huo%2C+Stephen&rft.date=2023-09-01&rft.pub=Elsevier+Inc&rft.issn=2152-2650&rft.eissn=2152-2669&rft.volume=23&rft.spage=S223&rft.epage=S223&rft_id=info:doi/10.1016%2FS2152-2650%2823%2900847-9&rft.externalDocID=S2152265023008479 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2152-2650&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2152-2650&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2152-2650&client=summon |